Literature DB >> 15538246

Elucidation of factors determining formation of calcium phosphate stones.

Charles Y C Pak1, Beverley Adams-Huet.   

Abstract

PURPOSE: In this study we compared the effect of the urinary concentration of calcium with that of oxalate on the urinary relative saturation ratio (RSR) of calcium oxalate and brushite in patients with pure or mixed calcium phosphate stones.
MATERIALS AND METHODS: A retrospective data analysis was performed of urinary stone risk analysis in 133 patients with pure or mixed calcium phosphate stones (30% or greater). Correlation was sought between stone events and urinary stone risk factors, and between brushite and urinary constituent RSRs before and after adjustment for variables.
RESULTS: The formation rates of total events and stone surgeries weakly but significantly correlated with RSR urinary brushite (total events r = 0.22, p = 0.01) but not with RSR calcium oxalate. Urinary RSR brushite significantly correlated positively with urinary calcium (r = 0.67, p <0.0001), phosphorus and pH. After adjustment RSR brushite inversely correlated with citrate (r = -0.3, p = 0.0006). However, it did not correlate with oxalate.
CONCLUSIONS: In stone formers with calcium phosphate or mixed calcium oxalate-calcium phosphate stones the stone formation rate depends on the urinary saturation of brushite but not of calcium oxalate. RSR brushite is determined by the urinary concentration of calcium, phosphate, citrate and pH but not by oxalate. Hypercalciuria should be controlled in patients with idiopathic calcareous renal calculi who form stones of pure or mixed calcium phosphate.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15538246     DOI: 10.1097/01.ju.0000140959.32579.44

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

1.  Cooperation of phosphates and carboxylates controls calcium oxalate crystallization in ultrafiltered urine.

Authors:  Bernd Grohe; Brian P H Chan; Esben S Sørensen; Gilles Lajoie; Harvey A Goldberg; Graeme K Hunter
Journal:  Urol Res       Date:  2011-01-14

2.  Nephrolithiasis in topiramate users.

Authors:  Naim M Maalouf; Joshua P Langston; Paul C Van Ness; Orson W Moe; Khashayar Sakhaee
Journal:  Urol Res       Date:  2010-12-17

3.  Composition and morphology of phosphate stones and their relation with etiology.

Authors:  Michel Daudon; Hassan Bouzidi; Dominique Bazin
Journal:  Urol Res       Date:  2010-10-22

4.  Prevalence and spot urine risk factors for renal stones in children taking topiramate.

Authors:  Nicol Corbin Bush; Katherine Twombley; Justin Ahn; Carlos Oliveira; Susan Arnold; Naim M Maalouf; Khashayar Sakhaee
Journal:  J Pediatr Urol       Date:  2013-02-01       Impact factor: 1.830

5.  The influence of maternal and paternal history on stone composition and clinical course of calcium nephrolithiasis in subjects aged between 15 and 25.

Authors:  Angela Guerra; Andrea Ticinesi; Franca Allegri; Antonio Nouvenne; Silvana Pinelli; Giuseppina Folesani; Fulvio Lauretani; Marcello Maggio; Loris Borghi; Tiziana Meschi
Journal:  Urolithiasis       Date:  2016-04-01       Impact factor: 3.436

6.  Controlled synthesis of dicalcium phosphate dihydrate (DCPD) from metastable solutions: insights into pathogenic calcification.

Authors:  A D Rafeek; G Choi; L A Evans
Journal:  J Mater Sci Mater Med       Date:  2021-11-24       Impact factor: 3.896

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.